ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection

NCT03183141 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
263
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Seres Therapeutics, Inc.